Abpro Holdings, Inc. (ABP)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2017
Cash & Equivalents	1.26	2.85	0.72	7.33	6.56	14.52
Cash & Short-Term Investments	1.26	2.85	0.72	7.33	6.56	14.52
Cash Growth	74.41%	294.19%	-90.13%	11.70%	-54.84%	105.27%
Receivables	0.33	0.32	0.09	2.03	0.04	0.18
Prepaid Expenses	0.48	0.31	0.21	0.29	0.26	0.26
Restricted Cash	0.14	0.14	0.14	-	-	-
Other Current Assets	-	0.16	0.88	-	-	-
Total Current Assets	2.22	3.78	2.04	9.65	6.86	14.96
Property, Plant & Equipment	0.31	0.46	1.07	1.8	0.7	1.46
Other Intangible Assets	0.17	0.18	0.19	0.2	0.13	-
Long-Term Deferred Charges	-	-	-	-	-	0.62
Other Long-Term Assets	0.1	0.25	0.07	0.21	0.21	0.1
Total Assets	2.8	4.66	3.36	11.85	7.89	17.14
Accounts Payable	4.7	3.94	7.92	8.15	1.91	0.53
Accrued Expenses	12.18	11.9	5.38	1.9	2.35	1.6
Short-Term Debt	2.95	2.87	1.74	-	-	-
Current Portion of Leases	0.3	0.46	0.7	0.76	0.21	-
Current Income Taxes Payable	0.37	0.37	-	-	-	-
Current Unearned Revenue	-	-	-	0.06	-	0.1
Other Current Liabilities	0.11	0.08	-	-	-	0.39
Total Current Liabilities	20.61	19.61	15.74	10.87	4.47	2.62
Long-Term Leases	-	-	0.46	1.12	0.35	-
Long-Term Unearned Revenue	-	-	-	-	-	0.3
Other Long-Term Liabilities	-	-	-	-	-	0.37
Total Liabilities	20.61	19.61	16.19	11.99	4.82	3.29
Common Stock	0.01	0.01	0	0.01	0.01	0.01
Additional Paid-In Capital	101.63	100.6	19.92	17.61	13.59	6.5
Retained Earnings	-119.99	-116.1	-108.87	-93.87	-76.65	-28.95
Treasury Stock	-	-	-0.03	-0.03	-0.03	-0.03
Total Common Equity	-18.36	-15.5	-88.98	-76.28	-63.09	-22.47
Minority Interest	0.55	0.55	0.55	0.55	0.55	0.55
Shareholders' Equity	-17.81	-14.95	-12.84	-0.14	3.07	13.85
Total Liabilities & Equity	2.8	4.66	3.36	11.85	7.89	17.14
Total Debt	3.25	3.33	2.89	1.87	0.56	-
Net Cash (Debt)	-1.99	-0.48	-2.17	5.45	6	14.52
Net Cash Growth	-	-	-	-9.15%	-58.69%	105.27%
Net Cash Per Share	-0.06	-0.02	-0.11	0.59	0.65	1.23
Filing Date Shares Outstanding	60.79	51.24	9.27	9.23	9.27	11.84
Total Common Shares Outstanding	50.98	50.83	9.27	9.23	9.27	11.81
Working Capital	-18.39	-15.83	-13.7	-1.22	2.39	12.34
Book Value Per Share	-0.36	-0.30	-9.60	-8.26	-6.80	-1.90
Tangible Book Value	-18.53	-15.67	-89.17	-76.48	-63.22	-22.47
Tangible Book Value Per Share	-0.36	-0.31	-9.62	-8.28	-6.82	-1.90
Machinery	1.17	1.17	1.17	1.12	1.12	1.05
Leasehold Improvements	0.79	0.79	0.79	0.79	0.79	0.77

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q